Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS). (Q41429836)
Jump to navigation
Jump to search
scientific article published on 13 March 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS). |
scientific article published on 13 March 2015 |
Statements
1 reference
Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS). (English)
1 reference
Stanislas Pol
1 reference
Patrick Marcellin
1 reference
Marc Bourlière
1 reference
Jean-Pierre Bronowicki
1 reference
Victor de Ledinghen
1 reference
Christophe Hézode
1 reference
Fabien Zoulim
1 reference
Albert Tran
1 reference
Dominique G Larrey
1 reference
Vlad Ratziu
1 reference
Laurent Alric
1 reference
Robert H Hyland
1 reference
Deyuan Jiang
1 reference
Brian Doehle
1 reference
Phillip S Pang
1 reference
William T Symonds
1 reference
G Mani Subramanian
1 reference
John G McHutchison
1 reference
François Habersetzer
1 reference
Dominique Guyader
1 reference
Jean-Didier Grangé
1 reference
Lawrence Serfaty
1 reference
Sophie Metivier
1 reference
Vincent Leroy
1 reference
Armand Abergel
1 reference
13 March 2015
1 reference
1 reference
15
1 reference
4
1 reference
397-404
1 reference
Identifiers
1 reference
1 reference